Axe Compute (AGPU) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
20 Jul, 2026Company overview and business model
Provides high-performance GPU compute infrastructure for AI workloads, sourcing GPU capacity from hardware manufacturers and deploying it for enterprise clients under long-term service agreements.
Offers two main customer models: custom large-scale infrastructure deployments and rapid access to third-party GPU capacity.
Maintains a legacy oncology drug discovery business, but is exploring strategic alternatives for this non-core segment.
Holds a significant reserve of ATH tokens, the native utility token of the Aethir decentralized GPU network, to secure immediate compute access.
Financial performance and metrics
As of July 17, 2026, the market value of common stock held by non-affiliates is $76.6 million, based on 11,150,560 shares at $6.87 per share.
Strategic Compute Reserve includes approximately 6.148 billion ATH tokens valued at $27.0 million as of July 17, 2026.
Entered a 36-month, $260 million enterprise infrastructure contract in April 2026 for a dedicated cluster of 2,304 NVIDIA B300 GPUs.
Use of proceeds and capital allocation
Net proceeds will be used for general corporate purposes, working capital, funding compute services, infrastructure expansion, and growing the Strategic Compute Reserve.
May allocate funds for capital expenditures, IP or technology acquisitions, and potential investments or acquisitions in complementary businesses.
Management has broad discretion over allocation, with no binding commitments to specific acquisitions.
Latest events from Axe Compute
- AI compute infrastructure provider seeks up to $1B for growth, leveraging ATH token reserves.AGPU
Registration filing2 Jul 2026 - AI infrastructure provider seeks to raise $1B for GPU expansion and strategic reserves.AGPU
Registration filing9 Jun 2026 - $260M contract and $4.3B pipeline drive AI compute pivot; Q1 net loss $7.7M, revenue $35K.AGPU
Q1 20266 Jun 2026 - Raised $343.5M, secured $12M in contracts, and ended 2025 with a $233M net loss.AGPU
Q4 202517 May 2026 - Q2 2024 saw a $3.2M loss, cost cuts, and new AI/ML partnerships amid going concern risks.AGPU
Q2 20241 Feb 2026 - Registering 1.98M shares for resale; proceeds from warrant exercises fund operations.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology firm shifts capital to Aethir tokens, heightening volatility and regulatory risk.AGPU
Registration Filing16 Dec 2025 - AI oncology and ATH-focused treasury strategy drive growth amid high digital asset risk.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology and ATH-focused treasury strategy create high growth and risk exposure.AGPU
Registration Filing16 Dec 2025